• Citer

A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.

par Catimel, G;Vermorken, Jan Baptist;Clavel, Michel;de Mulder, Pieter;Judson, I R;Sessa, C;Piccart-Gebhart, Martine ;Bruntsch, U;Verweij, Jaap;Wanders, Jantien
Référence Annals of oncology, 5, 6, page (543-547)
Publication Publié, 1994-07

Article révisé par les pairs

• Détails
• Contenu

Titre:	A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.
Auteur:	Catimel, G; Vermorken, Jan Baptist; Clavel, Michel; de Mulder, Pieter; Judson, I R; Sessa, C; Piccart-Gebhart, Martine; Bruntsch, U; Verweij, Jaap; Wanders, Jantien
Informations sur la publication:	Annals of oncology, 5, 6, page (543-547)
Statut de publication:	Publié, 1994-07
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Gemcitabine
	Head and neck cancer
	Phase II study
MeSH keywords:	Adult
	Aged
	Alanine Transaminase -- blood
	Antimetabolites, Antineoplastic -- administration & dosage
	Antimetabolites, Antineoplastic -- adverse effects
	Antimetabolites, Antineoplastic -- therapeutic use
	Aspartate Aminotransferases -- blood
	Carcinoma, Squamous Cell -- drug therapy
	Deoxycytidine -- administration & dosage
	Deoxycytidine -- adverse effects
	Deoxycytidine -- analogs & derivatives
	Deoxycytidine -- therapeutic use
	Europe
	Fatigue -- chemically induced
	Female
	Head and Neck Neoplasms -- drug therapy
	Humans
	Liver -- drug effects
	Liver -- enzymology
	Male
	Middle Aged
	Neutropenia -- chemically induced
	Remission Induction
Note générale:	Clinical Trial
	Clinical Trial, Phase II
	Journal Article
	Multicenter Study
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:scp/0028241688
	info:pmid/7918127